Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancerShunichi Sugawara, Kazuhiko Nakagawa, Jin‐Hyoung Kang et al.|Annals of Oncology|2021Cited by 202